기업 정보 불러오는 중
Just reported
Q1 FY2027 results
From Resmed's results release of 2026년 10월 29일; its quarterly report has since been filed.
Revenue
Actual
US$1.41B
+5.9% y/y
-3.3% q/qGuided
—
No guide given
EPS, GAAP
Actual
US$2.92
+23% y/y
+11% q/qGuided
—
No guide given
Operating income, GAAP
Actual
US$453M
+1.4% y/y
+1.0% q/qGuided
—
No guide given
Company outlook
Full year 2027
- EPS, adjustedUS$12.00 – US$12.25First given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Resmed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
Highest-graded in Medical Instruments and Supplies
Graded A or B and worth $2B or more: A first, then the largest.
ISRGIntuitive Surgical, Inc.US$152.5BA+
MDLNMedline Inc.US$52.6BA
ALCAlcon Inc.US$35BA
BLCOBausch & Lomb CorpUS$7.6BA-
ATRCAtriCure, Inc.US$2.9BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026년 10월 21일CBGraded C, now B
MCKMckesson Corporation2026년 11월 4일BAGraded B, now A
CVSCVS Health Corp2026년 11월 4일BAGraded B, now A
EWEdwards Lifesciences Corporation2026년 11월 4일BAGraded B, now A
BIIBBiogen Inc.2026년 10월 28일BAGraded B, now A
어떻게 돈을 버는가
- Sleep and breathing devices, masks, and related products88%
- Residential care software12%
매출 비중은 quarter ended 2026-03-31 기준 추정치이며, 제출된 보고서의 수치가 아닙니다.
경쟁 상대
- PHGPhilipsD
- 규모
- US$28.9B
- 이익률
- 0.0%
- FPHAFFisher & Paykel Healthcare
무엇을 파는가6
AirSense 11
A connected machine that delivers continuous or automatically adjusted air pressure to treat sleep apnea.
AirCurve 11
A bilevel breathing machine that provides different pressure levels for breathing in and out, for people needing more support or with complex breathing disorders.
Astral ventilators
Ventilators that provide breathing support, including for people receiving care at home.
3개 더 보기
AirTouch N30i, AirTouch F30i, and AirFit F40 masks
Masks that connect a person to a breathing machine during sleep; the named models include fabric and silicone designs.
myAir and AirView
Software for patients to engage with their sleep treatment and for providers to connect with and support patients.
Brightree and MEDIFOX DAN
Software products for residential care and home medical equipment providers.
누가 사는가3
- Home medical equipment and durable medical equipment providers buy and supply devices and masks for people prescribed breathing treatment.
- Residential care providers buy software such as Brightree and MEDIFOX DAN.
- Patients use ResMed's breathing devices, masks, and patient software, often with support from medical equipment providers and clinicians.
무엇에 기대고 있고, 무엇이 무너뜨릴 수 있는가
사업이 기대고 있는 것
- 1Manufacturing depends on electronic components and freight; the company has cited rising costs in both.
- 2Astral corrective work uses electronic components that are being prioritized for existing patients and device servicing.
- 3Sales depend on clinicians diagnosing sleep and breathing conditions and providers helping patients start and continue treatment.
잘못될 수 있는 일
- 1A field safety action involving Astral ventilators requires corrective work and has led ResMed to suspend new Astral sales during fiscal 2027.
- 2Inflation in electronic components and freight can outpace manufacturing productivity; modest price increases may be constrained by customers' reimbursement arrangements.
- 3Device and mask sales depend on patients being diagnosed, prescribed treatment, and supported through setup and ongoing use.
Resmed Inc. 소개
ResMed makes devices that help people breathe during sleep and ventilators for people who need breathing support. It also sells masks and software for patients, medical equipment providers, and residential care providers. Its sleep products include machines that connect with patient and provider software.
- 본사
- San Diego, California
- 설립
- 1989
- 임직원 수
- More than 11,000 (as of 2026-08-06, high)
- 상장 시장
- NYSE
- 회계연도 종료
- June 30
Resmed Inc.이(가) 미국 증권거래위원회(SEC)에 직접 제출한 공시로 만들었습니다. 수치는 보고된 그대로이며, 주당 이력은 오늘의 주식 수 기준으로 재계산했습니다. 이것은 사업을 설명하는 자료입니다. 투자 자문이 아니며 어떤 매수나 매도도 권유하지 않습니다.
